Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Respiration; International Review of Thoracic Diseases
|
January 1, 1978
Respiratory drive in idiopathic alveolar hypoventilation
D Patakas, G Louridas, K Stavropoulos
Brain and Cognition
|
December 10, 1999
Individual differences in callosal efficiency: correlation with attention
L Rueckert, D Baboorian, K Stavropoulos, et al.
Revista Clinica Espanola
|
May 3, 2021
[Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic]
D Patoulias, A Boulmpou, K Imprialos, et al.
Revista Clinica Espanola
|
June 25, 2021
Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic
D Patoulias, A Boulmpou, K Imprialos, et al.
Diabetes & Metabolism
|
May 22, 2020
Glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints
D Patoulias, A Katsimardou, M-S Kalogirou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Respiration; International Review of Thoracic Diseases
|
January 1, 1978
Respiratory drive in idiopathic alveolar hypoventilation
D Patakas, G Louridas, K Stavropoulos
Brain and Cognition
|
December 10, 1999
Individual differences in callosal efficiency: correlation with attention
L Rueckert, D Baboorian, K Stavropoulos, et al.
Revista Clinica Espanola
|
May 3, 2021
[Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic]
D Patoulias, A Boulmpou, K Imprialos, et al.
Revista Clinica Espanola
|
June 25, 2021
Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic
D Patoulias, A Boulmpou, K Imprialos, et al.
Diabetes & Metabolism
|
May 22, 2020
Glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints
D Patoulias, A Katsimardou, M-S Kalogirou, et al.
Page
of 1